GENIE Therapeutics is currently launching multiple gene therapies through the FDA pipeline. This breakthrough platform developed with Johns Hopkins, and NIH funding, has blockbuster potential. With revolutionizing aesthetics, it can be used across all full-body aesthetic skin conditions.
Company Details
- Employees
- 8
- Address
- Genie Therapeutics, Inc. 1207 Delaware Ave #1118, Wilmington,de,19806,united States
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- https://genietherapeutics.com/
- Keywords
- RB Brands.
- HQ
- Wilmington, DE
Genie Therapeutics Questions
Genie Therapeutics's website is https://genietherapeutics.com/
Genie Therapeutics's LinkedIn profile is https://www.linkedin.com/company/genie-therapeutics
Genie Therapeutics has
8 employees.
View email and phone details for 8
employees at Genie Therapeutics.
Genie Therapeutics's industry is
Investment Management
Genie Therapeutics's top competitors are
Spinlife,
Charhon Callahan Robson & Garza, Pllc,
Function Therapeutics,
Tmg Chemicals(Shanghai) Company Limited,
Cmp Pharma, Inc.,
Greek Orthodox Ladies Philoptochos Society, Inc.,
Kartha Pharmaceuticals Inc,
Gilad Creative Media,
Medicovestor, Inc.,
Rb Brands.
Genie Therapeutics's categories are Investment Management
